Literature DB >> 29313453

A PINK1-mediated mitophagy pathway decides the fate of tumors-to be benign or malignant?

Hui Qian1, Xiaojuan Chao1, Wen-Xing Ding1.   

Abstract

Macroautophagy/autophagy plays a dual role in cancer depending on the stage of tumorigenesis. Autophagy prevents tumor initiation by suppressing chronic tissue damage, inflammation, accumulation of damaged organelles and genome instability. Autophagy can also sustain tumor metabolism and provide nutrients for tumor growth and survival via nutrient recycling. Moreover, autophagy is required for benign tumors to progress to malignant tumors. Emerging evidence indicates that autophagy or mitophagy can inactivate tumor suppressors such as TP53/TRP53/p53 to promote tumor progression once carcinogenesis has been initiated.

Entities:  

Keywords:  Autophagy; hepatocellular carcinoma; mitophagy; p53; tumorigenesis

Mesh:

Substances:

Year:  2018        PMID: 29313453      PMCID: PMC5959334          DOI: 10.1080/15548627.2018.1425057

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  16 in total

1.  Autophagy-deficient mice develop multiple liver tumors.

Authors:  Akito Takamura; Masaaki Komatsu; Taichi Hara; Ayako Sakamoto; Chieko Kishi; Satoshi Waguri; Yoshinobu Eishi; Okio Hino; Keiji Tanaka; Noboru Mizushima
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

2.  Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis.

Authors:  Jessie Yanxiang Guo; Gizem Karsli-Uzunbas; Robin Mathew; Seena C Aisner; Jurre J Kamphorst; Anne M Strohecker; Guanghua Chen; Sandy Price; Wenyun Lu; Xin Teng; Eric Snyder; Urmila Santanam; Robert S Dipaola; Tyler Jacks; Joshua D Rabinowitz; Eileen White
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

3.  Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy.

Authors:  Hong-Min Ni; Benjamin L Woolbright; Jessica Williams; Bryan Copple; Wei Cui; James P Luyendyk; Hartmut Jaeschke; Wen-Xing Ding
Journal:  J Hepatol       Date:  2014-05-09       Impact factor: 25.083

4.  Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis.

Authors:  Yoshinori Takahashi; Domenico Coppola; Norimasa Matsushita; Hernani D Cualing; Mei Sun; Yuya Sato; Chengyu Liang; Jae U Jung; Jin Q Cheng; James J Mulé; W Jack Pledger; Hong-Gang Wang
Journal:  Nat Cell Biol       Date:  2007-09-23       Impact factor: 28.824

5.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

6.  Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3.

Authors:  Guillermo Mariño; Natalia Salvador-Montoliu; Antonio Fueyo; Erwin Knecht; Noboru Mizushima; Carlos López-Otín
Journal:  J Biol Chem       Date:  2007-04-17       Impact factor: 5.157

Review 7.  Mitophagy: mechanisms, pathophysiological roles, and analysis.

Authors:  Wen-Xing Ding; Xiao-Ming Yin
Journal:  Biol Chem       Date:  2012-07       Impact factor: 3.915

Review 8.  Autophagy modulation as a potential therapeutic target for diverse diseases.

Authors:  David C Rubinsztein; Patrice Codogno; Beth Levine
Journal:  Nat Rev Drug Discov       Date:  2012-09       Impact factor: 84.694

Review 9.  Mitochondrial dynamics and mitochondrial quality control.

Authors:  Hong-Min Ni; Jessica A Williams; Wen-Xing Ding
Journal:  Redox Biol       Date:  2014-11-20       Impact factor: 11.799

10.  p53 status determines the role of autophagy in pancreatic tumour development.

Authors:  Mathias T Rosenfeldt; Jim O'Prey; Jennifer P Morton; Colin Nixon; Gillian MacKay; Agata Mrowinska; Amy Au; Taranjit Singh Rai; Liang Zheng; Rachel Ridgway; Peter D Adams; Kurt I Anderson; Eyal Gottlieb; Owen J Sansom; Kevin M Ryan
Journal:  Nature       Date:  2013-12-04       Impact factor: 49.962

View more
  6 in total

1.  Sp1 is Involved in Vertebrate LC-PUFA Biosynthesis by Upregulating the Expression of Liver Desaturase and Elongase Genes.

Authors:  Yuanyou Li; Jianhong Zhao; Yewei Dong; Ziyan Yin; Yang Li; Yang Liu; Cuihong You; Óscar Monroig; Douglas R Tocher; Shuqi Wang
Journal:  Int J Mol Sci       Date:  2019-10-12       Impact factor: 5.923

2.  Deciphering the dual role and prognostic potential of PINK1 across cancer types.

Authors:  Katherine Dai; Daniel P Radin; Donna Leonardi
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

Review 3.  Targeting PINK1 Using Natural Products for the Treatment of Human Diseases.

Authors:  Yan-Qin Li; Fan Zhang; Li-Ping Yu; Jian-Kang Mu; Ya-Qin Yang; Jie Yu; Xing-Xin Yang
Journal:  Biomed Res Int       Date:  2021-10-30       Impact factor: 3.411

4.  Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer.

Authors:  Yongqi Zhen; Zhaoxin Yuan; Jiahui Zhang; Yao Chen; Yuning Fu; Yi Liu; Leilei Fu; Lan Zhang; Xian-Li Zhou
Journal:  Cell Death Dis       Date:  2022-04-19       Impact factor: 9.685

Review 5.  Role and Mechanisms of Mitophagy in Liver Diseases.

Authors:  Xiaowen Ma; Tara McKeen; Jianhua Zhang; Wen-Xing Ding
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

6.  Zinc oxide nanoparticles induce toxicity in CAL 27 oral cancer cell lines by activating PINK1/Parkin-mediated mitophagy.

Authors:  Jianfeng Wang; Shutao Gao; Shuyu Wang; Zhaonan Xu; Limin Wei
Journal:  Int J Nanomedicine       Date:  2018-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.